International Pricing & Reimbursement
Global Pricing & Reimbursement Strategies
An effective pricing strategy is a key component of the international marketing plan. Many factors influence pricing decisions including corporate objectives, market size, price controls and reimbursement systems in the different markets, number of close comparators, prices of competitors, etc. A strategy built around a uniform global price for a product is usually not feasible because of different regulations and expectations in the various markets. When customers differ in terms of willingness to pay, a differential pricing strategy may yield maximum revenues, however the risk of competition from parallel imports is also a factor in some markets. Setting a premium price may limit market access as a product may not be reimbursed or may have limited reimbursement under public and/or private health plans.
PDCI offers expertise in the following areas:
- International pricing analysis
- European Union, United States, Japan, Canada, and emerging markets
- Payer Research (in collaboration with an international network of P&R experts)
- Competitor pricing analysis
- Developing innovative pricing strategies
- Launch sequencing
- Evaluating the risks of parallel (cross-border) trade For more information please contact Neil Palmer, Janice D'Angelo or Susan Neale
International Pharmaceutical Pricing Database
PDCI Market Access has developed a comprehensive database of international pharmaceutical prices. The data are invaluable for conducting primary pricing research for drugs in development (eg, go, no-go decisions), for global pricing & reimbursement strategies for new drugs or filing with regulatory authorities (e.g. PMPRB in Canada).
The price database has been assembled from the official published price lists in each country. Prices in major markets in Europe, North America, as well as Australia are tracked on a regular basis with prices in other markets (eg, Asia, Latin America) sourced on an ad-hoc basis.
Wholesale and pharmacy prices are recorded for all dosage forms, strengths, and package sizes. Ex-factory prices have been calculated by adjusting the published prices to remove mark-ups, VAT, etc. The adjustments are based on the official algorithms/formulae published in each country. The data can be provided in local currencies and/or standardized to a single currency (eg, Euros, US Dollars, British Pounds, Canadian Dollars).
Data are provided to clients on a request basis, and can be customized to reflect the specific drugs needed, and can be delivered in a variety of formats from printed reports to excel spreadsheets. A sample report is available for downloading. Larger requests can be provided in a database format complete with report writer and exchange calculator. The cost is dependent on number of data elements requested. We typically complete small requests within 24 hours and larger requests generally within 5 business days.
For further information on PDCI Market Access’s International Price Database please contact Arvind Mani.
